Drug Shortage Report for ASMANEX TWISTHALER

Last updated on 2020-02-21 History
Report ID 80590
Drug Identification Number 02438690
Brand name ASMANEX TWISTHALER
Common or Proper name mometasone furoate dry powder inhaler
Company Name ORGANON CANADA INC.
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 100MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size 30dose
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-11-06
Actual start date 2019-11-05
Estimated end date 2020-02-20
Actual end date 2020-02-20
Shortage status Resolved
Updated date 2020-02-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16766 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-844-820-5468 dpoc.canada@organon.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2020-02-21 English Compare
v20 2020-02-20 French Compare
v19 2020-02-20 English Compare
v18 2020-02-14 English Compare
v17 2019-11-06 English Compare
v16 2019-11-05 French Compare
v15 2019-11-05 English Compare
v14 2019-11-01 English Compare
v13 2019-10-31 French Compare
v12 2019-10-31 English Compare
v11 2019-10-30 English Compare
v10 2019-10-28 English Compare
v9 2019-10-04 English Compare
v8 2019-09-30 French Compare
v7 2019-09-30 English Compare
v6 2019-08-01 English Compare
v5 2019-06-19 French Compare
v4 2019-06-19 English Compare
v3 2019-06-02 English Compare
v2 2019-04-05 French Compare

Showing 1 to 20 of 21